MARIMED INC. (MRMD): Submission of Matters to a Vote of Security Holders
MARIMED INC. (MRMD) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. Exhibit 99.1 MariMed Stockholders Approve Proposed Reverse Stock Split NORWOOD, MA, October 29, 2026 - MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQB: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced that the Compa
How this was made
The 30-second read
Why it matters
The filing provides the first public disclosure of the split proposal, creating uncertainty about future liquidity and listing prospects.
Market read
Primary corporate action for a small‑cap cannabis stock; relevance limited to investors in MRMD and peers.
What to watch
Potential regulatory approval timeline for a U.S. exchange listing and the impact of upcoming cannabis legislation.
Background
MariMed Inc. (CSE: MRMD, OTCQB: MRMD) is a multi‑state cannabis operator that filed an 8‑K announcing shareholder approval of a reverse stock split.
Ticker impact
Stockholders approved a proposed reverse stock split of MRMD at a special meeting, authorizing the board to implement a 1-for-50 to 1-for-100 split.
likely pressure as the market prices in uncertainty over implementation and potential uplisting benefits
Reverse splits are often viewed skeptically unless they enable a listing on a major exchange; the board may choose not to execute, creating uncertainty.
Market effects
May influence other small‑cap cannabis stocks as investors watch for uplisting precedents.
Limited to U.S. OTC and Canadian cannabis markets.
Low; no broader macro or sector shift.
Counterpoint
If the split is executed, the reduced share count could attract institutional interest and trigger a short‑term rally.
Key entities
- companyMariMed Inc.
Cannabis operator seeking a reverse stock split to improve share price and potential uplisting.
- personJon Levine
CEO of MariMed who announced the shareholder approval.
